Article
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
Oncotarget - 29 Sept 2015
Huang Ruea-Yea, Eppolito Cheryl, Lele Shashikant, Shrikant Protul, Matsuzaki Junko, Odunsi Kunle
Abstract excerpt
The immune co-inhibitory receptors lymphocyte activation gene-3 (LAG3) and programmed cell death 1 (PD1) synergistically contribute to autoimmunity and tumor evasion. Here we demonstrate how they collaborate and interact to regulate T cell function. We first show that LAG3 and PD1 are co-expressed on both OVA-specific and non-specific T cells infiltrating murine ovarian tumors. Dual antibody blockade or genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
